Billings Clinic
Especially For:

Clinical Trials

Title   Merck V212-011
Description   A Phase III Randomized, Placebo-Controlled, Clinical Trial to Study the Safety and Efficacy of V212 in Adult Patients with Solid Tumor or Hematologic Malignancy
IRB Number   Schulman 201106376
Inclusion/Notes   Patients must have had chicken pox. Cannot have had the chickenpox or shingles vaccination. Cannot have had shingles in the past year. This is a partial list of Inclusion criteria. Multiple other criteria must be met to be eligible for this clinical trial.
Status   Temporary HOLD
Start Date   01/06/2012
Principal Investigator (PI)   Brock Whittenberger, MD
Contact Name   Tauna Jeffery, RN
Contact Email
Phone   (406) 435-7484
Alternate Phone   (406) 435-7480
Fax   (406) 435-7489
Print This Page
Email to a Friend
Home | Contact | Site Map | Site Privacy Policy | Terms & Conditions | Patient Privacy Policy | Medical Records | Fast Command
2800 10th Ave. North | P.O. Box 37000 | Billings, Montana 59107 | 406.238.2500
© Copyright 2014 Billings Clinic. All Rights Reserved.